Tuesday 17 November 2026
Export BRLS’s income statement to Excel — free account
Borealis Foods Inc.
BRLSConsumer Defensive Packaged Foods
Borealis Foods Inc.’s revenue for fiscal 2025 (year ended December 2025) was $30.1 million, up 8.71% from fiscal 2024.
- Revenue
- +7.63%
- EPS
- n/m
- Free cash flow
- n/m
- Total debt
- −98.8%
Quarter to March 2026, against a year earlier
0.90
0.06
−6.25%
Follow BRLS
Alert me
Ratios over time Q2 FY25 to Q1 FY26
Returns on capital
ROIC was 0.0% in Q1 FY26, the highest of these four quarters. ROE, at 133.0%, is far above it because equity is small against the capital the business uses.
| Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | |
|---|---|---|---|---|
| ROE | −5303.1% | 465.4% | 190.5% | 133.0% |
| ROIC | −56.1% | 0.0% | 0.0% | 0.0% |
Debt
Net debt is 0.10× a year’s EBITDA.
| Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | |
|---|---|---|---|---|
| Net debt / EBITDA | −9.0× | −2.5× | −0.2× | 0.1× |
Cash cycle, in days
Customers pay in 21 days, inventory is held 47 days and suppliers are paid in 233. Suppliers fund 165 days of working capital.
| Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | |
|---|---|---|---|---|
| Cash cycle | −70 | −83 | −125 | −165 |
| Days to pay suppliers | 200 | 203 | 220 | 233 |
| Days to be paid | 30 | 34 | 32 | 21 |
Per share, from Q2 FY25
Since Q2 FY25, per share: revenue has grown 7.3%.
| Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | |
|---|---|---|---|---|
| Revenue | 1.0× | 1.0× | 1.1× | 1.1× |
| Mar '26 | Dec '25 | Sep '25 | Jun '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
4 | 5 | — | — |
+8 more TTM periods Free account |
| 132.98% | 190.49% | 465.41% | (5,303.13%) | ||
| (33.48%) | (33.72%) | (31.02%) | (32.08%) | ||
ROIC |
0.00% | 0.00% | 0.00% | (56.06%) | |
Return on Tangible Assets |
85.07% | 106.21% | 177.60% | (126.82%) | |
Average Days of Receivables |
20.78 | 32.13 | 33.69 | 29.73 | |
Free Cash Flow per Share |
(0.25) | (0.31) | (0.23) | (0.39) | |
Free Cash Flow |
(5.35) | (6.66) | (4.84) | (8.38) | |
Capital Expenditures |
— | (0.07) | (0.26) | (0.72) | |
| Other line items | |||||
Cash ROIC |
24.41% | 35.68% | 52.87% | (50.49%) | |
Accounts Receivable Turnover |
17.38 | 13.04 | 10.18 | 11.71 | |
Accounts Payable Turnover |
1.79 | 1.93 | 2.23 | 2.45 | |
Inventory Turnover |
4.81 | 4.21 | 3.42 | 3.48 | |
Average Days of Payables |
233.42 | 220.46 | 203.29 | 199.92 | |
Days of Inventory on Hand |
47.49 | 62.96 | 86.90 | 100.06 | |
Tax Rate |
0.00 | (0.01) | 0.00 | (0.01) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
44.54% | 48.36% | 55.65% | 61.28% | |
Share Based Compensation of Revenue |
1.39% | 1.48% | 1.13% | 1.10% | |
Interest Coverage |
(1.65) | (1.84) | (2.27) | (2.91) | |
Operating CF/Net income |
0.29 | 0.35 | 0.25 | 0.39 | |
Depreciation/Fixed assets |
0.05 | 0.05 | 0.05 | 0.05 | |
Capex/Depreciation |
0.00 | (0.03) | (0.12) | (0.33) | |
Revenue per Share |
1.43 | 1.40 | 1.30 | 1.33 | |
Operating CF per Share |
(0.25) | (0.31) | (0.21) | (0.36) | |
Capex per Share |
0.00 | 0.00 | (0.01) | (0.03) | |
Capex to Sales |
0.00 | 0.00 | 0.01 | 0.03 |
Columns are period end dates